ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $320,396 | -21.6% | 30,543 | -1.8% | 0.00% | -33.3% |
Q3 2023 | $408,772 | +5.7% | 31,109 | +1.4% | 0.00% | 0.0% |
Q2 2023 | $386,681 | -6.4% | 30,689 | -3.1% | 0.00% | -25.0% |
Q1 2023 | $413,137 | -25.1% | 31,658 | +1.3% | 0.00% | -20.0% |
Q4 2022 | $551,497 | +14.9% | 31,264 | -0.8% | 0.01% | 0.0% |
Q3 2022 | $480,000 | +2.8% | 31,528 | +0.1% | 0.01% | 0.0% |
Q2 2022 | $467,000 | -37.4% | 31,493 | -4.9% | 0.01% | -16.7% |
Q1 2022 | $746,000 | +20.1% | 33,133 | -1.5% | 0.01% | +20.0% |
Q4 2021 | $621,000 | +20.8% | 33,646 | -12.5% | 0.01% | +25.0% |
Q3 2021 | $514,000 | -35.3% | 38,452 | -10.5% | 0.00% | -33.3% |
Q2 2021 | $795,000 | +15.1% | 42,944 | -6.6% | 0.01% | 0.0% |
Q1 2021 | $691,000 | +1.3% | 45,989 | -2.7% | 0.01% | 0.0% |
Q4 2020 | $682,000 | +70.9% | 47,262 | -3.6% | 0.01% | +50.0% |
Q3 2020 | $399,000 | +60.9% | 49,046 | +33.8% | 0.00% | +33.3% |
Q2 2020 | $248,000 | -7.5% | 36,647 | -3.9% | 0.00% | -40.0% |
Q1 2020 | $268,000 | -70.4% | 38,118 | -58.6% | 0.01% | -54.5% |
Q4 2019 | $904,000 | -20.7% | 92,073 | -11.4% | 0.01% | -21.4% |
Q3 2019 | $1,140,000 | -18.9% | 103,864 | -14.0% | 0.01% | -12.5% |
Q2 2019 | $1,405,000 | +19.7% | 120,796 | -1.8% | 0.02% | +14.3% |
Q1 2019 | $1,174,000 | -2.9% | 123,026 | -1.9% | 0.01% | -12.5% |
Q4 2018 | $1,209,000 | -31.6% | 125,399 | +1.1% | 0.02% | -5.9% |
Q3 2018 | $1,767,000 | +19.2% | 123,982 | +0.4% | 0.02% | +13.3% |
Q2 2018 | $1,483,000 | -1.9% | 123,549 | +1.0% | 0.02% | 0.0% |
Q1 2018 | $1,511,000 | -20.1% | 122,351 | -5.9% | 0.02% | -16.7% |
Q4 2017 | $1,892,000 | +29.9% | 130,051 | +27.0% | 0.02% | +5.9% |
Q3 2017 | $1,457,000 | +49.3% | 102,385 | +33.8% | 0.02% | +21.4% |
Q2 2017 | $976,000 | +2.5% | 76,500 | +1.9% | 0.01% | +7.7% |
Q1 2017 | $952,000 | +12.7% | 75,100 | -9.3% | 0.01% | +8.3% |
Q4 2016 | $845,000 | -17.0% | 82,758 | +7.1% | 0.01% | -20.0% |
Q3 2016 | $1,018,000 | +3.2% | 77,271 | -0.5% | 0.02% | +7.1% |
Q2 2016 | $986,000 | -22.3% | 77,671 | -19.2% | 0.01% | -17.6% |
Q1 2016 | $1,269,000 | -10.9% | 96,071 | +3.7% | 0.02% | -10.5% |
Q4 2015 | $1,425,000 | +34.3% | 92,671 | +8.3% | 0.02% | +26.7% |
Q3 2015 | $1,061,000 | -27.9% | 85,532 | -25.8% | 0.02% | -11.8% |
Q4 2014 | $1,471,000 | +2.7% | 115,200 | +7.9% | 0.02% | -5.6% |
Q3 2014 | $1,432,000 | -11.1% | 106,800 | +6.4% | 0.02% | -5.3% |
Q2 2014 | $1,611,000 | -11.9% | 100,400 | -1.0% | 0.02% | -17.4% |
Q1 2014 | $1,828,000 | +4.9% | 101,400 | -10.0% | 0.02% | +9.5% |
Q4 2013 | $1,742,000 | -4.8% | 112,700 | -8.4% | 0.02% | -8.7% |
Q3 2013 | $1,830,000 | +2.6% | 123,100 | -10.7% | 0.02% | -4.2% |
Q2 2013 | $1,783,000 | +1.5% | 137,800 | +6.6% | 0.02% | -4.0% |
Q1 2013 | $1,757,000 | – | 129,300 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |